MYC and cancer: In addition to the downstream effectors of YAP, ID1 and c-MYC have been defined as the markers of BCSCs because ID1( +) cells are enriched for self-renewal in tumorsphere [74, 75] and c-MYC drives a stem-like phenotype in cancer [76].